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Objective: Derivatives of 3,7-diazabicyclo[3.3.1]nonan-9-one attract considerable attention from pharmacists for the treatment of a wide range 
of diseases. According to this interest, the novel derivatives of 3-cyclopropanmethyl-7-alkoxyalkyl-3,7-diazabicyclo[3.3.1]nonan-9-one with 
isopropoxypropyl and ethoxypropyl substituents in the position 7 had been synthesized to study their biological activity and toxicity. The practical 
significance of the work is in the accumulation and development of scientific representations about diazabicyclic compounds, methods for their 
synthesis, structure, and properties, which can subsequently be used in a targeted design and identification of even more complex systems, as well 
as in the development of further research in the field of 3,7-diazabicyclo[3.3.1]nonanes. For this purpose, complexes of the synthesized compounds 
with β-cyclodextrin are obtained and their biological activity is investigated at the Department of Pharmacology of S.D. Asfendiyarov Kazakh National 
Medical University with the aid of the pharmacological tests.
Methods: An experimental study of local anesthetic activity on the models of infiltration, conduction anesthesia, and acute toxicity of synthesized 
molecules was carried out using primary screening methods.
Results: As a result of pharmacological screening, it has been found that the compounds exhibit local anesthetic activity and low toxicity and was 
recommended for in-depth study of their pharmacological properties.
Conclusion: It turned out that a nature of the N-alkoxyalkyl radical does not affect the toxicity of cyclopropanmethyl- substituted bispidines. In the 
series of O-benzoyloximes of bispidinones, the isopropoxypropyl- substituted analog is 1.3 times less toxic than ethoxypropyl- one.
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INTRODUCTION
An analysis of current trends in the medical use of drugs indicates the 
ongoing gradual replacement of obsolete drugs with more effective and 
safe drugs of novel generations. Therefore, research on the search for 
novel potentially biologically active substances is relevant.
The aim of research is the synthesis of novel potentially 
pharmacologically active derivatives of 3-cyclopropanmethyl-7-
alkoxyalkyl-3,7-diazabicyclo[3.3.1]nonan-9-one, as well as the 
establishment of the structure and evaluation of their biological activity.
The interest of chemists in the study of heteroanalogs of bicyclo[3.3.1]
nonane is due to the unique properties of these compounds, which 
makes them valuable from a theoretical and practical point of 
view [1-10]. It is also known that methylenecyclopropane residue is 
a valuable structural unit of bioactive compounds, particularly, opiate 
antagonists [11,12].
1-(3-Isopropoxypropyl- and 3-ethoxypropyl-)-4-oxopiperidine (1, 2) 
as starting substrates was used to obtain the target bispidines (3-14) 
according to Fig. 1.
The reaction products were obtained with high yields as viscous 
oils. Monitoring of the progress of the reaction was carried out by 
TLC on alumina. The structure of bispidinone derivatives (3-10) was 
determined by nuclear magnetic resonance (NMR) and infrared (IR) 
spectroscopies.
To study the biological properties of the novel derivatives of 
3,7-diazabicyclo[3.3.1]nonan-9-ones, their complexes with 
β-cyclodextrin had been synthesized (11-14).
METHODS
Experimental chemical part
NMR spectra of the studied compounds were recorded on a JEOL JNM-
ECA400 spectrometer with an operating frequency on carbon nuclei of 
100.53 MHz in CDCl3 with hexamethyldisiloxane as internal standard. 
Elemental analysis data were consistent with calculated values. IR 
spectra were recorded on a Nicolet 5700 instrument between KBr 
plates. Column chromatography and thin-layer chromatography were 
carried out on alumina (Al2O3) of the third degree of activity, Rf of the 




In a three-necked flask equipped with a stirrer, reflux condenser, 
and dropping funnel, 60 ml of methanol was deoxygenated under 
a stream of nitrogen. After 30 min, a mixture of 4.6 g (0.059 mol) of 
cyclopropanemethylamine, 7.2 g (0.46 mol) of paraform, 3.1 ml of 
concentrated hydrochloric acid, and 4.5 ml of glacial acetic acid was 
added and stirred for 15 min in the atmosphere of nitrogen. A solution 
of 11.7 g (0.059 mol) of 1-(3-isopropoxypropyl)piperidin-4-one 
(1) and 4.5 ml of glacial acetic acid in 15 ml of methanol was added 
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dropwise. After 10 h of heating the reaction mixture at 60–65°C, a 
second equivalent of paraform was added and held for another 12 h 
at the same temperature. The solvent was evaporated, the residue was 
dissolved in 30 ml of water. The extraction of neutral products was 
carried out with diethyl ether. The aqueous layer was alkalinized to 
pH 12 and the organic part was extracted with chloroform, dried over 
MgSO4. The solvent was evaporated, the resulting product was purified 
on a column of aluminum oxide, benzene:dioxane 5:1. 9.3 g (73.6%) of 
3-cyclopropanmethyl-7-(3-isopropoxypropyl)-3,7-diazabicyclo[3.3.1]
nonan-9-one (3) was obtained in the form of a light yellow oil with 
Rf=0.23 (Al2O3, benzene:isopropanol = 6:1).
	 Found,	%:	C	69.41,	Н	10.24, N 9.55. C17H30N2O2.
	 Calculated,	%:	C	69.38,	Н	10.20,	N	9.52.
 IR spectrum, cm-1: 1734 (νC=О), 1122 (νC-О-С).





In a three-necked flask equipped with a stirrer, reflux condenser, 
and dropping funnel, 80 ml of methanol was deoxygenated under 
a stream of nitrogen. After 30 min, a mixture of 5.2 g (0.070 mol) of 
cyclopropanemethylamine, 8.7 g (0.140 mol) of paraform, 3.8 ml of 
concentrated hydrochloric acid, and 5.6 ml of glacial acetic acid was 
added and stirred for 15 min under nitrogen atmosphere. A solution of 
13.4 g (0.070 mol) of 1-(3-ethoxypropyl)piperidin-4-one (2) and 6.2 ml 
of glacial acetic acid in 11 ml of methanol was added dropwise. After 
heating the reaction mixture for 10 h at 60–65°C, the second equivalent 
of paraform is added and the mixture was held for another 12 h at 
the same temperature. Throughout the reaction, the reaction mixture 
is purged with a stream of nitrogen. The solvent was evaporated, the 
residue was dissolved in 113 ml of water. The extraction of neutral 
products was carried out with diethyl ether. The aqueous layer was 
alkalinized to pH 12 and the organic part was extracted with chloroform, 
dried over MgSO4. The solvent was evaporated, the resulting product 
was purified on a column of aluminum oxide, benzene:dioxane = 
5:1. 16.1 g (79%) of 3-cyclopropanmethyl-7-(3-ethoxypropyl)-3,7-
diazabicyc-lo[3.3.1]nonan-9-one (4) was obtained in the form of a light 
yellow oil with Rf=0.50 (Al2O3, benzene:isopropanol = 6:1).
	 Found,	%:	C	68.38,	Н	10.12,	N	9.92.	C16H28N2O2.
	 Calculated,	%:	C	68.57,	Н	10.00,	N	10.00.
 IR spectrum, cm-1: 1736 (νC=О), 1118 (νC-О-С).





A mixture of 2.0 g (0.0068 mol) of 3-cyclopropanmethyl-7-(3-
isopropoxy-propyl)-3,7-diazabicyclo[3.3.1]nonan-9-one (3) and 1.09 g 
(0.034 mol) of hydrazine hydrate (99% solution) in 20 ml of triethylene 
glycol at 60°C was added 4.7 g (0.084 mol) of KOH. The reaction 
mixture was heated to 150°C and stirred at this temperature for 4 h. 
At a temperature of 190–200°C, water and excess hydrazine were 
removed by evaporation. After cooling, 33 ml of distilled water was 
added, extracted with diethyl ether, and dried over anhydrous MgSO4. 
The solvent was evaporated, the obtained product was purified by 
column chromatography on Al2O3, benzene:dioxane 5:1. 2.1 g (42%) of 
3-cyclopropanmethyl-7-(3-isopropoxypropyl)-3,7-diazabicyclo[3.3.1]




 IR spectrum, cm-1: 1112 (νC-О-С).





A mixture of 5.0 g (0.018 mol) 3-cyclopropanmethyl-7-(3-ethoxypropyl)-
3,7-diazabicyclo[3.3.1]nonan-9-one (4) and 2.88 g (0.090 mol) hydrazine 
Fig. 1: Synthetic routes to the target bispidines
 5th International Conference on Pharmacy and Pharmaceutical Science (ICPPS) 2020 70
Int J App Pharm, Vol 13, Special Issue 1, 2021
 Malmakova et al.
hydrate (99% solution) in 52.5 ml of triethylene glycol at 60°C add 12.5 g 
(0.22 mol) of KOH. The reaction mixture was heated to 150°C and stirred 
at this temperature for 4 h. At a temperature of 190–200°C, water and 
excess hydrazine were removed by evaporation. After cooling, 64 ml of 
distilled water was added, extracted with diethyl ether, and dried over 
anhydrous MgSO4. The solvent was evaporated, the obtained product 
was purified by column chromatography on Al2O3, benzene:dioxane 5:1. 
2.1 g (42% of theory) of 3-cyclopropanmethyl-7-(3-ethoxypropyl)-3,7-
diazabicyclo[3.3.1]nonane (6) was obtained in the form of a light yellow 
oil with Rf=0.34 (Al2O3, benzene:isopropanol = 7:1).
	 Found,	%:	C	72.32,	Н	11.12,	N	10.65.	C16H30N2O.
	 Calculated,	%:	C	72.18;	Н	11.27;	N	10.52.
 IR spectrum, ν, cm-1: 1111 (νC-О-С).





3.0 g (0.0102 mol) of 3-cyclopropanmethyl-7-(3-isopropoxypropyl)-
3,7-diazabicyclo[3.3.1]nonan-9-one (3) in 60 ml of ethyl alcohol and 
1.23 g (0.0153 mol) of pyridine were placed in a three-necked flask 
equipped with a mechanical stirrer, reflux condenser with a calcium 
chloride tube, and dropping funnel. While stirring, 1.84 g (0.0265 mol) 
of hydroxylamine hydrochloride was added. The reaction mixture 
was heated at 110–120°C for 20 h, the solvent was evaporated, and 
the residue was dissolved in 15 ml of water, alkalized with NaOH to 
pH 12, extracted with chloroform, and dried over anhydrous MgSO4. 
The solvent was evaporated, the residue was purified by column 
chromatography on Al2O3, benzene:dioxane =5:1. 1.83 g (59%) 
of oxime of 3-cyclopropanmethyl-7-(3-isopropoxypropyl)-3,7-
diazabicyclo[3.3.1]nonan-9-one (7) was obtained in the form of light 
yellow oils with Rf=0.016 (Al2O3, benzene:isopropanol = 20:1).
	 Found,	%:	C	66.05,	Н	10.65,	N	13.63.	C17H31N3O2.
	 Calculated,	%:	C	66.02,	Н	10.67,	N	13.59.
 IR spectrum, cm−1: 1668 (νC=N), 3074 (νО-H).
 13С-NMR	spectrum,	δ, ppm (CDCI3):	38.1	(С1),	32.0	(С5), 59.5; 59.7 




6.0 g (0.0155 mol) of 3-cyclopropanmethyl-7-(3-ethoxypropyl)-3,7- 
diazabicyclo[3.3.1]nonan-9-one (4) in 160 ml of ethyl alcohol and 
3 ml (0.0375 mol) of pyridine were placed in a three-necked flask 
equipped with a mechanical stirrer, reflux condenser with a calcium 
chloride tube, and dropping funnel. With stirring, 4.5 g (0.065 mol) 
of hydroxylamine hydrochloride was added. The reaction mixture 
was heated at 110–120°C for 20 h, the solvent was evaporated, and 
the residue was dissolved in 10 ml of water, alkalized with NaOH 
to pH 12, extracted with chloroform, and dried over anhydrous 
MgSO4. The solvent was evaporated, the residue was purified by 
column chromatography on Al2O3, benzene:isopropanol-20:1. 5.4 
g (85%) of oxime of 3-cyclopropanmethyl-7-(3-ethoxypropyl)-3,7- 
diazabicyclo[3.3.1]nonan-9-one (8) was obtained in the form of light 
yellow oils with Rf=0.06 (Al2O3, benzene:isopropanol = 20:1).
	 Found,	%:	C	65.22,	Н	9.89,	N	14.36.	C16H29N3O2.
	 Calculated,	%:	C	65.08,	Н	9.83,	N	14.24.
 IR spectrum, cm-1: 1643 (νC=N), 3291 (νО-H).
 13С-NMR	spectrum,	δ, ppm (CDCI3):	37.0	(С1),	32.5	(С5), 58.5, 58.3 




1.5 g (0.0048 mol) of oxime of 3-cyclopropanmethyl-7-(3-
isopropoxypropyl)-3,7-diazabicyclo[3.3.1]nonan-9-one (7) was mixed 
with 15 ml of absolute benzene and a mixture of 2 ml of absolute 
benzene and 0.6 ml (0.0048 mol) of benzoyl chloride was added 
dropwise. Reaction took place at room temperature. At the end, 10 ml of 
distilled water was added to the reaction mixture and neutralized with 
potash to pH 10–11, the product was extracted with chloroform, the 
combined extracts were dried over anhydrous MgSO4. The solvent was 
evaporated and residue was distilled in vacuo. 1.9 g (91 % of theory) of 
O-benzoyloxime of 3-cyclopropanmethyl-7-(3-isopropoxypropyl)-3,7-
diazabicyclo[3.3.1]nonan-9-one was obtained in the form of a yellow 
oil (9), Rf=0.77 (Al2O3, benzene:isopropanol = 7:1).
	 Found,	%:	C	69.64,	Н	8.24,	N	10,20.	C24H35N3O3.
	 Calculated,	%:	C	69.73,	Н	8.48,	N	10.17.
 IR spectrum, cm-1: 1745 (νC=О), 1641 (νC=N).
 13С-NMR	spectrum,	δ, ppm (CDCI3):	38.7,	34.6	(С1, 5), 57.6, 59.3, 59.6, 





4.0 g (0.01356 mol) of oxime of 3-cyclopropanmethyl-7-(3-
ethoxypropyl)-3,7-diazabicyclo[3.3.1]nonan-9-one (8) was mixed 
with 40 ml of absolute benzene and a mixture of 12 ml of absolute 
benzene and 1.9 ml (0.01356 mol) of benzoyl chloride was added 
dropwise. Reaction took place at room temperature. At the end, 15 ml 
of distilled water was added to the reaction mixture and neutralized 
with potash to pH 10–11, the product is extracted with chloroform, the 
combined extracts were dried over anhydrous MgSO4. The solvent was 
evaporated and residue was distilled in vacuo. 2.4 g (46% of theory) 
of O-benzoyloxime of 3-cyclopropanmethyl-7-(3-ethoxy-propyl)-3,7-
diazabicyclo[3.3.1]nonan-9-one was obtained in the form of a yellow 
oil (10), Rf=0.30 (Al2O3, benzene:isopropanol = 7:1).
	 Found,	%:	C	69.12,	Н	8.34,	N	10.65.	C23H33N3O3.
	 Calculated,	%:	C	69.17,	Н	8.27,	N	10.52.
 IR spectrum, cm-1: 3300.4 (νO-H), 1675.4 (νC=N).
 13С-NMR	spectrum,	δ, ppm (CDCI3):	37.2,	33.6	(С1, 5), 57.0, 57.4, 57.9, 




diazabicyclo[3.3.1]nonane with β-cyclodextrin (11)
Hot solutions of 0.9 g (0.0033 mol) of 3-cyclopropanmethyl-7-(3-
isopropoxypropyl)-3,7-diazabicyclo[3.3.1]nonane (5) in 25 ml of ethyl 
alcohol and 3.7 g (0.0033 mol) of β-cyclodextrin in 35 ml of distilled water 
were mixed together. The mixture was placed in a drying cupboard, ethanol 




diazabicyclo[3.3.1]nonane with β-cyclodextrin (12)
Hot solutions of 1.7 g (0.0064 mol) of 3-cyclopropanmethyl-7-(3-
ethoxypropyl)-3,7-diazabi-cyclo[3.3.1]nonane (6) in 25 ml of ethyl alcohol 
and 7.2 g (0.0064 mol) of β-cyclodextrin in 45 ml of distilled water were 
mixed together. The mixture was placed in a drying cupboard, ethanol and 
water were evaporated at 50–55°C to produce 8.7 g of compound (12).
	 Found,	%:	C	59.61,	Н	7.26,	N	1.93.	C58H100N2O36.
	 Calculated,	%:	C	59.71,	Н	7.14,	N	2.00.
Complex of O-benzoyloxime of 3-cyclopropanmethyl-7-(3-
isopropoxypropyl)-3,7-diazabi-cyclo[3.3.1]nonan-9-one with 
β-cyclodextrin (13)
Hot solutions of 1.9 g (0.004 mol) of O-benzoyloxime of 
3-сyclopropanmethyl-7-(3-isopropoxypro-pyl)-3,7-diazabicyclo[3.3.1]
nonan-9-one (9) in 25 ml of ethyl alcohol and 4.8 g (0.004 mol) of 
β-cyclodextrin in 30 ml of distilled water were mixed together. The 
mixture was placed in a drying cupboard, ethanol and water were 
evaporated at 50–55°C to produce 5.4 g of compound (13).
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	 Found,	%:	C	51.16,	Н	6.69,	N	2.66.	C66H105N3O38.
	 Calculated,	%:	C	51.20,	Н	6.79,	N	2.71.
Complex of O-benzoyloxime of 3-cyclopropanmethyl-7-(3-ethoxypropyl)-
3,7-diazabicyclo-[3.3.1]nonan-9-one with β-cyclodextrin (14)
Hot solutions of 1.4 g (0.00366 mol) of O-benzoyloxime of 
3-сyclopropanmethyl-7-(3-ethoxypropyl)-3,7-diazabicyclo[3.3.1]
nonan-9-one (10) in 20 ml of ethyl alcohol and 4.15 g (0.00366 
mol) of β-cyclodextrin in 30 ml of distilled water were mixed 
together. The mixture was placed in a drying cupboard; ethanol 





An experimental study of local anesthetic activity on the models 
of infiltration, conduction anesthesia, and acute toxicity of the 
synthesized molecules was carried out using primary screening 
methods in six animals in each series at the Department of 
Pharmacology of S.D. Asfendiyarov Kazakh National Medical 
University in accordance with the “Rules for the use of experimental 
animals” (European Convention No. 123, 1986, Helsinki Declaration 
2000) and the State Standard of the Republic of Kazakhstan “Good 
Laboratory Practice” (the main provisions of ST RK 1613-2006) 
and the “Rules of Good Laboratory Practice of the Customs Union” 
(Attachment to the Decision of the Commission of the Customs Union, 
No. 564, dated March 2, 2011). Besides, the team has a positive 
opinion from the LEC (local expert commission) of S.D. Asfendiyarov 
Kazakh National Medical University (Minutes No. 7 (58) dated 
September 12, 2017) on the compliance of work with experimental 
animals.
The anesthetic activity of the synthesized compounds was compared 
with those of widely used anesthetics – trimecaine, lidocaine, and 
novocaine.
The evaluation of infiltration anesthesia was studied on guinea 
pigs according to the Bulbring-Wade method. The following values 
were determined: The depth of anesthesia (anesthesia index), the 
duration of deep anesthesia, and the total duration of the anesthetic 
effect.
The conduction anesthesia was examined through the modified 
tail flick method on rats. It allows to measure the duration of deep 
anesthesia and the total duration of the anesthetic effect of the 
compound.
The study of acute toxicity was carried out on mice of the same species, 
sex, age, and weighing 18–22 g. Acute toxicity (LD50) was determined 
by a single subcutaneous injection of aqueous solutions of the 
compounds.
The local anesthetic effect and acute toxicity of novel derivatives of 
3,7-diazabicyclo[3.3.1] nonan-9-one in the form of complexes with 





RESULTS AND DISCUSSION 
The infiltration anesthesia
It turned out that on the model of infiltration anesthesia in a bispidines 
family, the most active is LA-2, the anesthesia index of which is 
35.60±0.19 (Table 1). In addition, it caused a longer complete anesthesia 
of 34.00±1.26 min, while the total duration of action was 43.00±1.84 
min. Replacing the ethoxypropyl radical in the LA-2 compound with an 
isopropoxypropyl- one led to a three-fold decrease in activity.
Among the two of O-benzoyloximes of 3,7-diazabicyclo[3.3.1]nonan-9-
ones, LA-3 with cyclopropanmethyl and isopropoxypropyl radicals at 
nitrogen atoms was active, its anesthesia index was 35.60±1.18, and 
the duration of deep anesthesia was equal to 34.80±0.98 min. The total 
duration of action was 43.10±1.17 min. Replacing the isopropoxypropyl 
radical with a ethoxypropyl- one led to a decrease in activity (LA-4) 
(anesthesia index was 29.16±1.45; the duration of deep anesthesia was 
16.00±2.90 min; and the total analgesic effect lasted (29.16±2.06 min). 




It should be noted that bispidines and O-benzoyloximes on the model 
of conduction anesthesia did not show any significant effect. However, 
LA-1 can be distinguished, which in terms of total duration of action is 
comparable to novocaine and inferior to trimecaine and lidocaine.
In the group of O-benzoyloximes, according to the duration of total 
anesthesia, LA-4 exceeded trimecaine and novocaine (Table 2).
Acute toxicity
The acute toxicity of bispidine derivatives is presented in Table 3.
Complex	 of	 3-сyclopropan-






3 , 7 - d i a z a b i c yc l o [ 3 . 3 . 1 ]
nonane	with	β-cyclodextrin
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As follows from the data of Table 3, derivatives of 3,7-diazabicyclo[3.3.1]
nonan-9-one are low toxic compounds. The most harmless 
is LA-3 (complex of O-benzoyloxy-3-cycloproylmethyl-7-(3-
isopropoxypropyl)-3,7-diazabicyclo[3.3.1]nonan-9-one with β-CD), 
where the LD50 is 825.0 mg/kg.
It turned out that a nature of the N-alkoxyalkyl radical does not affect the 
toxicity of cyclopropanmethyl- substituted bispidines (LA-1 and LA-2). 
In the series of O-benzoyloximes of bispidinones, the isopropoxypropyl- 
substituted analog is 1.3 times less toxic than ethoxypropyl- one.
CONCLUSION
In this research, derivatives of 3,7-diazabicyclo[3.3.1]nonan-9-ones 
were synthesized and the biological properties were studied for their 
complexes with β-cyclodextrin.
Thus, as a result of structural modifications of bicyclic piperidines, 
novel low toxic substances possessing a local anesthetic effect 
had been obtained, the activity of which depends on the nature 
of the N-alkoxyalkyl- and substituents at the position 9 of the 
3,7-diazabicyclo[3.3.1]nonane ring. The most harmless is the complex 
of O-benzoyloxy-3-cycloproylmethyl-7-(3-isopropoxypropyl)-3,7-
diazabicyclo[3.3.1]nonan-9-ketoxime with β-CD, where the LD50 is 
825 mg/kg. The compound was recommended for in-depth study of its 
pharmacological properties.
Moreover, the results of research will be used in a targeted design 
and identification of even more complex systems on the base of 
3,7-diazabicyclo[3.3.1]nonan-9-ones with different biological activity.
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